WallStreetZenWallStreetZen

NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?

Insider buying vs selling

Have Can Fite Biopharma Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CANF insiders and whales buy or sell their stock.

CANF Shareholders

What type of owners hold Can Fite Biopharma Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.04%320,175$1.26MInstitution
Susquehanna International Group LLP0.01%59,374$234.53kInstitution
Fifth Third Bancorp0.00%30,000$118.50kInstitution
Virtu Financial LLC0.00%28,771$113.65kInstitution
Ubs Group Ag0.00%17,362$68.58kInstitution
Two Sigma Securities LLC0.00%14,574$57.57kInstitution
Stifel Financial Corp0.00%12,000$47.40kInstitution
National Bank Of Canada0.00%6,000$23.70kInstitution
Citigroup Inc0.00%5,535$21.86kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

CANF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CANF0.06%0.00%
NAVB2.42%97.58%Net BuyingNet Buying
PTIX3.46%0.88%Net Buying
BPTS0.05%0.00%
AYTU22.88%77.12%Net BuyingNet Buying

Can Fite Biopharma Stock Ownership FAQ

Who owns Can Fite Biopharma?

Can Fite Biopharma (NYSEMKT: CANF) is owned by 0.06% institutional shareholders, 0.00% Can Fite Biopharma insiders, and 99.94% retail investors. Morgan Stanley is the largest individual Can Fite Biopharma shareholder, owning 320,175.00 shares representing 0.04% of the company. Morgan Stanley's Can Fite Biopharma shares are currently valued at $1.28M.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.